Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biaffin is a Germany-based bioanalytical services and contract research company focused on biomolecular interaction analysis using surface plasmon resonance (SPR) and Biacore instrumentation. The company provides kinetic and affinity measurements, assay development, hit validation, lead optimization support, antibody and biosimilar characterization, mechanism-of-action studies, and concentration analysis for pharmaceutical, biotech, diagnostics, and academic customers. In addition to services, Biaffin supplies kinase research reagents through its proteinkinase.de distribution platform, including recombinant proteins, kinase inhibitors, phosphatases, cytokines, antibodies, and bioluminescence-based assays. The business appears to operate as a specialized commercial service provider and reagent vendor rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biaffin.